IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3yfFVLN
No comments:
Post a Comment